Jeremy Bender, CHIEF EXECUTIVE OFFICER at Day One Biopharmaceuticals, Inc. (DAWN), sold 32,116 shares at $6.77 ($217K) on 2025-08-18, disclosed to the SEC on 2025-08-19.
Seasonal sale ($217k) by CHIEF EXECUTIVE OFFICER — this insider has traded DAWN in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.77 | 16,058 | $109K | 50.0% |
| 2 | $6.77 | 16,058 | $109K | 50.0% |
| Total | $6.77 avg | 32,116 | $217K | 100% |
| Filing → |
| DAWN | SELL | 2025-05-19 | $175K | — | Filing → |
| DAWN | SELL | 2025-02-21 | $288K | — | Filing → |
| DAWN | SELL | 2024-11-19 | $279K | — | Filing → |